An attenuation of tumor growth was observed in the B16-BL6 tumors upon c-Myb induction in vivo, and there was increased tumor cell sensitivity to CD8+ T cell–mediated killing in vitro, albeit not statistically significant. The gene discussed is MYB; the disease is neoplasm.